&w=3840&q=100)
Biocon shares slip 3% as Q1 results miss estimates; should you sell?
The biopharma company's stock fell as much as 3.60 per cent during the day to ₹331 per share, the lowest level since June 6 this year. The stock pared losses to trade 0.9 per cent higher at ₹340.4 apiece, compared to a 0.22 per cent advance in Nifty 50 as of 11:45 AM.
Shares of the company fell for the second straight day and currently trade at 1.5 times the average 30-day trading volume, according to Bloomberg. The counter has fallen 7.2 per cent this year, compared to a 3.3 per cent advance in the benchmark Nifty 50. Biocon has a total market capitalisation of ₹45,349.81 crore.
Biocon Q1 results
The Bengaluru-based company reported a 95.2 per cent Y-o-Y drop in consolidated net profit at ₹31 crore in Q1FY26, compared to ₹660 crore in the same period last year. The Q1 FY25 profit included a one-time divestment gain, impacting this year's base.
The firm's revenue rose 15 per cent to ₹4,022 crore on a like-for-like basis after adjusting for the one-time gain in the base quarter. Operating revenue increased 15 per cent to ₹3,942 crore in Q1 FY26, up from ₹3,433 crore in Q1 FY25.
The generics business reported revenue of ₹697 crore, a 6 per cent Y-o-Y increase, while the CRDMO business, Syngene, reported revenue of ₹875 crore, up 11 per cent Y-o-Y.
'Biocon opened FY26 with a strong performance, driven by continued gains in biosimilars and CRDMO, and a steady showing in generics. The recent QIP has strengthened our balance sheet and enabled us to increase our ownership in Biocon Biologics by facilitating the exit of structured equity investors, aligning capital structure with long-term strategic priorities,' said Kiran Mazumdar-Shaw, chairperson, Biocon Group.
Analysts in Biocon earnings
Nuvama Institutional Equities said Biocon's Q1FY26 revenue and Ebitda missed consensus estimates by 2 per cent and 11 per cent, respectively, due to weakness in the generics segment.
The brokerage noted market share gains in key biosimilar products, steady margins, and upcoming launches of bAspart, denosumab, bevacizumab, and bEylea as positive signs. However, it said execution will be critical to achieving high growth, with the generics segment still dragging and consistent margin delivery yet to be demonstrated amid elevated costs from new facilities.
Nuvama maintained its 'Hold' rating on the stock, with a revised target price of ₹365, up from ₹345 earlier.
Motilal Oswal said Biocon's Q1FY26 financial performance came in below expectations, primarily due to a sharp decline in generics sales and higher operating expenses. The brokerage noted that Biocon is building growth levers across its generics, biologics, and Syngene businesses, with an encouraging product pipeline in both generics and biologics.
It cut its earnings estimates by 7 per cent for FY26 and 3 per cent for FY27, while maintaining a 'Buy' rating with a target price of ₹410.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
41 minutes ago
- Time of India
Another tariff hit: Donald Trump signals levies on chips and steel; semiconductor duties may hit 300%
US President Donald Trump is loading another tariff bullet, this time aimed at semiconductor chips and steel. The move, expected to be announced in the coming weaks, could shake the already rattled global trade. 'I'll be setting tariffs next week and the week after on steel and on, I would say, chips,' Trump told reporters aboard Air Force One on Friday, as he travelled to Alaska for a meeting with Russian President Vladimir Putin. He said the rates would start lower to give companies time to ramp up manufacturing in the US, before rising steeply, similar to his approach on pharmaceuticals. 'I'm going to have a rate that is going to be lower at the beginning - that gives them a chance to come in and build - and very high after a certain period of time,' Reuters cited the US President. Trump further expressed confidence that firms would choose to manufacture domestically rather than face hefty duties. Earlier in February, Trump increased tariffs on steel and aluminium to 25%, then doubled them to 50% in May to support US manufacturers. It remains unclear if his latest comments signal another increase for the metals. Last week, Trump said he would impose a 100% tariff on semiconductors, with exemptions for companies committed to building in the US. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Secure Your Child's Future with Strong English Fluency Planet Spark Learn More Undo The US president hinted the rate on imported chips could be even higher. 'I'm going to have a rate that is going to be 200%, 300%?' he said, as quoted by Bloomberg. The White House has yet to explain how such exemptions would work, though Trump suggested Apple, which has pledged a $600 billion domestic manufacturing initiative, could benefit. Manufacturers and AI firms have been pressing for clarity, as chips are integral to a vast range of consumer products. Both semiconductors and pharmaceuticals have been under US commerce department investigation since April, a required step before tariffs can be imposed on national security grounds, a process that can drag on for months, Bloomberg reported. Trump also signalled that trade could be on the agenda with Putin. 'I noticed he's bringing a lot of business people from Russia, and that's good I like that because they want to do business,' Trump said. 'But they're not doing business until we get the war settled,' he said. In recent weeks, Trump has threatened new tariffs on Russian energy buyers, including a 50% levy on goods from India, and warned that Moscow could face higher economic costs if his meeting with Putin does not go well. Stay informed with the latest business news, updates on bank holidays , public holidays , current gold rate and silver price .
The Hindu
an hour ago
- The Hindu
City sees Independence Day celebrations in tricolour hues
Citizen collectives and organizations across the city held multiple activities and programmes to mark the 79th Independence Day. Volunteers from the St. Broseph Army, the volunteering wing of Broseph Foundation, a Bengaluru-headquartered NGO, came together to restore Freedom Wall, a visual tribute to India's national icons in Indiranagar. The volunteers scrubbed and sponged away layers of dirt and stains and swept the ground around the wall. 'This wasn't just about cleaning a wall, but it was about preserving a space that holds deep meaning for our community. It's a small but powerful way to honour our national heritage as we celebrate Independence Day,' said Tarini Shivnani, a volunteer. Competitions held As part of the Independence Day celebrations and 'Har Ghar Tiranga' campaign, the central office, Central Silk Board, organised drawing, painting, and letter writing competitions for jawans at Government School, Madiwala. Quiz, 'pick & speak' game, and eco-friendly Tiranga making was held for the employees. A movie screening of the film Parmanu and an awareness rally was also held. Scholarships for students Canara Bank celebrated the Independence Day by announcing scholarships for meritorious SC/ST girl students from underprivileged backgrounds, under the bank's Corporate Social Responsibility (CSR) programme 'Canara bank Dr. Ambedkar Vidya Jyothi Scholarship.' The scholarship will be distributed across 26 circle offices, 177 regional offices, and over 9,861 branches throughout the country. . The bank has also facilitated village adoption initiatives and the construction of toilets and sanitation facilities for girl students in rural schools under its CSR Programme. It also extended support to Sree Boomika Social Service Trust, which serves as an old-age home and orphanage, and persons with disabilities, through the Samarthanam Trust for the disabled by providing assistive devices. Week-long celebrations Canadian International School (CIS) celebrated Independence Day alongside its milestone of 30 years of international education. The week-long celebrations brought together students and staff from over 40 nationalities.
Mint
an hour ago
- Mint
US stocks today: Dow, S&P 500 hit record high, UnitedHealth shares jump over 10%. What is driving the surge?
US stocks today: Dow Jones and the S&P 500 hit a new record high on Friday, 15 August 2025, as the benchmark Dow Jones Industrial Average gained from UnitedHealth shares jumping over 10% on Wall Street. The shares of the insurance firm, UnitedHealth Group, jumped more than 10% on Friday after Warren Buffett's Omaha-based investment giant, Berkshire Hathaway, disclosed its stake in the troubled firm. UnitedHealth Group shares were trading 11.64% higher at $303.08 as of 10:19 a.m. (EDT) on Friday's US stock market session, compared to $271.49 at the previous Wall Street close. In the last five years, the shares of UnitedHealth Group have lost 6.62% in the US markets, and are down 47.85% in the last one-year period. On a year-to-date (YTD) basis, the stock has lost 40.08% in 2025. However, the shares of the firm have given US stock market investors more than 18.98% gains in the last five market sessions on Wall Street. UnitedHealth's market capitalisation (M-Cap) was at $245.88 billion as of the trading session on Friday, 15 August 2025. The shares of the insurance firm hit their 52-week low level at $234.60, while the 52-week high level was at $630.73, according to the data collected from MarketWatch. (This is a developing story. Please check back for updates)
